Intratumoral Heterogeneity, Its Contribution to Therapy Resistance and Methodological Caveats to Assessment

Por Renovanz, Mirjam, Kim, Ella L.
Publicado em 2014

No role of IFITM3 in brain tumor formation in vivo

Por Stankovic, Nevenka Dudvarski, Hoppmann, Nicola, Teodorczyk, Marcin, Kim, Ella L., Bros, Matthias, Giese, Alf, Zipp, Frauke, Schmidt, Mirko H.H.
Publicado no Oncotarget (2016)

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells

Por Barrantes-Freer, Alonso, Renovanz, Mirjam, Eich, Marcus, Braukmann, Alina, Sprang, Bettina, Spirin, Pavel, Pardo, Luis A., Giese, Alf, Kim, Ella L.
Publicado no PLoS One (2015)

Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells

Por Kim, Ella L., Wüstenberg, Robin, Rübsam, Anne, Schmitz-Salue, Christoph, Warnecke, Gabriele, Bücker, Eva-Maria, Pettkus, Nadine, Speidel, Daniel, Rohde, Veit, Schulz-Schaeffer, Walter, Deppert, Wolfgang, Giese, Alf
Publicado em 2010

Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance...

Por Tivnan, Amanda, Heilinger, Tatjana, Ramsey, Joanne M, O’Connor, Gemma, Pokorny, Jenny L, Sarkaria, Jann N, Stringer, Brett W, Day, Bryan W, Boyd, Andrew W, Kim, Ella L, Lode, Holger N, Cryan, Sally-Ann, Prehn, Jochen H.M
Publicado no Oncotarget (2017)

Selective Detection of the D-enantiomer of 2-Hydroxyglutarate in the CSF of Glioma Patients with Mutated Isocitrate Dehydrogenase

Por Kalinina, Juliya, Ahn, Jun, Devi, Narra S., Wang, Liya, Li, Yuancheng, Olson, Jeffrey J., Glantz, Michael, Smith, Thomas, Kim, Ella L., Giese, Alf, Jensen, Randy L., Chen, Clark C., Carter, Bob S., Mao, Hui, He, Miao, Van Meir, Erwin G.
Publicado no Clin Cancer Res (2016)